Add BrightSurf on Google Email

Science News Archive April 2021 - Page 39


Page 39 of 46

Are early treatments for cerebral palsy effective?

Research on early treatments for cerebral palsy has generated limited supportive data, but emerging efforts aim to improve developmental motor outcomes in children with the condition. Newer, more targeted interventions are being explored to provide novel insights and transform treatment approaches.

SourceWiley·JournalDevelopmental Medicine & Child Neurology·DateApr 7, 2021

New findings on how diabetes impacts bone health

Type 1 diabetes and diabetic neuropathy contribute to various bone structure impacts but don't fully explain higher fracture risk in patients. Balance and muscle strength also play a role in increased fracture risk, according to new findings.

SourceWiley·JournalJournal of Bone and Mineral Research·DateApr 7, 2021

Program may help patients with rheumatic diseases quit smoking

A new protocol called Quit Connect has been shown to increase electronic referrals to free, state-run tobacco quitlines among patients with rheumatic diseases. The program, which leverages electronic health record prompts for nurses and medical assistants, resulted in a 71% increase in referrals.

SourceWiley·JournalArthritis Care & Research·DateApr 7, 2021

The case for embedding equity into incident command

The authors argue that a structural change to national Hospital Incident Command System (HICS) guidelines is needed to ensure inclusion of an Equity Officer and health equity specialists. This change could help mitigate inequities in hospital responses during disasters, particularly for historically marginalized populations.

SourceBrigham and Women's Hospital·JournalAmerican Journal of Public Health·DateApr 7, 2021

The muon's magnetic moment fits just fine

Researchers estimated muon's magnetic field strength using a fully verified theory independent of experimental measurements. The result aligns with the standard model of particle physics, suggesting no need for new physics to explain the phenomenon.

SourcePenn State·JournalNature·DateApr 7, 2021

Clinical trial completion rates decline during COVID-19 pandemic

Global clinical trial completion rates dropped by 13-23% during the COVID-19 pandemic, according to a new study. The decline was most significant in trials funded by government, academic or medical entities, and was attributed to reduced patient enrollment and increased challenges in following up on patients.

SourcePenn State·JournalClinical and Translational Science·DateApr 7, 2021

Research brief: Reflecting sunlight could cool the Earth's ecosystem

A team of researchers explored the effect of solar radiation modification technologies on ecology, focusing on a specific strategy called stratospheric aerosol intervention (SAI) that creates a sulfate aerosol cloud in the stratosphere to reduce incoming sunlight and radiation. The study highlights the complexity of cascading relations...

SourceUniversity of Minnesota·JournalProceedings of the National Academy of Sciences·DateApr 7, 2021

Johns Hopkins Medicine expert creates comprehensive guide to new diabetes drugs

A clinical practice review article by Rita Kalyani provides a systematic approach for treating patients with diabetes and cardiovascular disease. The article recommends using GLP-1 receptor agonists and SGLT2 inhibitors, particularly for patients with heart or blood vessel disease, to reduce the risk of major cardiovascular events.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateApr 7, 2021

State immigrant policies and preterm births

A study of 3.4 million live births in 2018 found that criminalizing immigrant policies were associated with higher preterm birth rates for Black women born outside the US, while inclusive policies were linked to lower preterm birth rates for all women born outside the US and particularly White women outside the US.

SourceJAMA Network·JournalJAMA Network Open·DateApr 7, 2021

Testing a new way to tackle cancer

A collaboration between Michigan State University, Spectrum Health, and Niowave is testing a new radiotherapy approach for bladder cancer. The therapy combines radiotherapy with immunotherapy, which helps the patient's immune system fight off disease, aiming to improve safety and effectiveness.